ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells

Journal of Cell Science

Volumn 123, Issue 7, 2010, Pages 1171-1180

  Fang, Hsin Yuan ^a,b   Chang, Chia Ling ^c   Hsu, Shu Han ^c   Huang, Chih Yang ^c   Chiang, Shu Fen ^c   Chiou, Shiow Her ^c   Huang, Chun Hua ^c   Hsiao, Yi Ting ^c   Lin, Tze Yi ^b   Chiang, I Ping ^b   Hsu, Wen Hu ^d   Sugano, Sumio ^e   Chen, Chih Yi ^b   Lin, Ching Yuang ^b   Ko, Wen Je ^a   Chow, Kuan Chih ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

ATAD3A; Cisplatin sensitivity; Lung adenocarcinoma; Mitochondrial fragmentation

Indexed keywords

AAA ADENOSINE TRIPHOSPHATASE; AAA DOMAIN CONTAINING 3A PROTEIN; ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATASES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CISPLATIN; DISEASE PROGRESSION; DRUG RESISTANCE; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASM STAGING; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA;

EID: 77951200646     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.062034     Document Type: Article

References (30)

1. Black, J. D. (2000). Protein kinase C-mediated regulation of the cell cycle. Front Biosci. 5, D406-D423.
2. Chen, J. T., Lin, T. S., Chow, K. C., Huang, H. H., Chiou, S. H., Chiang, S. F., Chen, H. C., Chuang, T. L., Lin, T. Y. and Chen, C. Y. (2006). Cigarette smoking induces overexpression of HGF in type II pneumocytes and lung cancer cells. Am. J. Respir. Cell Mol. Biol. 34, 264-273.
3. Chen, J. T., Huang, C. Y., Chiang, Y. Y., Chen, W. H., Chiou, S. H., Chen, C. Y. and Chow, K. C. (2008). HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells. Am. J. Respir. Cell Mol. Biol. 38, 559-565.
4. Chiang, Y. Y. (2009). Hepatocyte growth factor induces hypoxia-related interleukin-8 expression in lung adenocarcinoma cells. Mol. Carcinog. 48, 662-670.
5. Chiang, Y. Y., Chen, S. L., Hsiao, Y. T., Huang, C. H., Lin, T. Y., Chiang, I. P., Hsu, W. H. and Chow, K. C. (2009). Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas. Mod. Pathol. 22, 1139-1150.
6. Chow, K. C. and Ross, W. E. (1987). Topoisomerase-specific drug sensitivity in relation to cell cycle progression. Mol. Cell. Biol. 7, 3119-3123.
7. de Brito, O. M. and Scorrano, L. (2008a). Mitofusin 2, a mitochondria-shaping protein with signaling roles beyond fusion. Antioxid. Redox. Signal 10, 621-633.
8. de Brito, O. M. and Scorrano, L. (2008b). Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456, 605-610.
9. Geuijen, C. A., Bijl, N., Smit, R. C., Cox, F., Throsby, M., Visser, T. J., Jongeneelen, M. A., Bakker, A. B., Kruisbeek, A. M., Goudsmit, J. et al. (2005). A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry. Eur. J. Cancer 41, 178-187.
10. Gires, O., Münz, M., Schaffrik, M., Kieu, C., Rauch, J., Ahlemann, M., Eberle, D., Mack, B., Wollenberg, B., Lang, S. et al. (2004). Profile identification of diseaseassociated humoral antigens using AMIDA, a novel proteomics-based technology. Cell Mol. Life Sci. 61, 1198-1207.
11. Gomez-Lazaro, M., Bonekamp, N. A., Galindo, M. F., Jordán, J. and Schrader, M. (2008). 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. Free Radic. Biol. Med. 44, 1960-1969.
12. Hirai, M., Gamou, S., Kobayashi, M. and Shimizu, N. (1989). Lung cancer cells often express high levels of protein kinase C activity. Jpn. J. Cancer Res. 80, 204-208.
13. Hirai, T. and Chida, K. (2003). Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J. Biochem. 133, 1-7.
14. Honda, S., Aihara, T., Hontani, M., Okubo, K. and Hirose, S. (2005). Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J. Cell Sci. 118, 3153-3161.
15. Hubstenberger, A., Labourdette, G., Baudier, J. and Rousseau, D. (2008). ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties. Exp. Cell Res. 314, 2870-2883.
16. Jackowski, S. (1996). Cell cycle regulation of membrane phospholipid metabolism. J. Biol. Chem. 271, 20219-20222.
17. Kaplan, E. L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
18. Knott, A. B., Perkins, G., Schwarzenbacher, R. and Bossy-Wetzel, E. (2008). Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505-518.
19. Kobayashi, E., Nakano, H., Morimoto, M. and Tamaoki, T. (1989). Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159, 548-553.
20. Mantel, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163-170.
21. Merkwirth, C. and Langer, T. (2008). Mitofusin 2 builds a bridge between ER and mitochondria. Cell 135, 1165-1167.
22. Pfanner, N. and Geissler, A. (2001). Versatility of the mitochondrial protein import machinery. Nat. Rev. Mol. Cell. Biol. 2, 339-349. (Pubitemid 33674046)
23. Remmele, W. and Schicketanz, K. H. (1993). Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol. Res. Pract. 189, 862-866.
24. Rosell, R., Moran, T., Fernanda Salazar, M., Mendez, P., De Aguirre, I., Ramirez, J. L., Isla, D., Cobo, M., Camps, C., Lopez-Vivanco, G. et al. (2006). The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer. Rev. Mal. Respir. 23, 16S131-16S136.
25. Schaefer, G., Shao, L., Totpal, K. and Akita, R. W. (2007). Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression. Cancer Res. 67, 1228-1238.
26. Schaffrik, M., Mack, B., Matthias, C., Rauch, J. and Gires, O. (2006). Molecular characterization of the tumor-associated antigen AAA-TOB3. Cell Mol. Life Sci. 63, 2162-2174.
27. Shiao, Y. J., Lupo, G. and Vance, J. E. (1995). Evidence that phosphatidylserine is imported into mitochondria via a mitochondria-associated membrane and that the majority of mitochondrial phosphatidylethanolamine is derived from decarboxylation of phosphatidylserine. J. Biol. Chem. 270, 11190-11198.
28. Sun, F. C., Wei, S., Li, C. W., Chang, Y. S., Chao, C. C. and Lai, Y. K. (2006). Localization of GRP78 to mitochondria under the unfolded protein response. Biochem. J. 396, 31-39.
29. Sun, S., Schiller, J. H. and Gazdar, A. F. (2007). Lung cancer in never smokers-a different disease. Nat. Rev. Cancer 7, 778-790.
30. Tavaluc, R. T., Hart, L. S., Dicker, D. T. and El-Deiry, W. S. (2007). Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines. Cell Cycle 6, 2554-2562.